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ABSTRACT (245 words) 
Objectives: Information concerning pre-stroke disability on stroke outcomes is 
lacking. We assessed pre-stroke disability in relation to post-stroke outcomes whilst in 
hospital. 
Design: Analysis of prospectively collected data from the Sentinel Stroke National 
Audit Programme (SSNAP). 
Setting: Four major UK hyperacute stroke units (HASUs) between 2014 and 2016. 
Participants: 1656 men (mean age ±SD=73.1yrs ±13.2) and 1653 women (79.3yrs 
±13.0) admitted with acute stroke. 
Main outcome measures: Pre-stroke disability, assessed by modified Rankin Scale 
(mRS), was tested against post-stroke adverse outcomes, adjusted for age, sex and 
coexisting morbidities. 
Results: Compared with patients with pre-stroke mRS score=0, individuals with pre-
stroke mRS scores=4 or 5 had greater adjusted risks of: moderately-severe or severe 
stroke on arrival (4.4% vs 22.1%, OR=4.5, 95%CI=2.9-7.1); urinary tract infection 
and/or pneumonia within seven days of admission (9.6% vs 34.7%, OR=3.4, 
95%CI=2.4-5.0); prolonged length-of-stay (LOS) on HASU (20.3% vs 34.6%, OR=1.6, 
95%CI=1.1-2.5) and mortality (7.2% vs 38.1%, OR=5.0, 95%CI=3.5-7.3).  Patients 
with mRS scores=2 or 3 had intermediate risk of adverse outcomes: but for those with 
mRS score=2 the highest risk of prolonged LOS on HASU (20.3% vs 41.8%, OR=2.4, 
95%CI=1.8-3.2) and for those with mRS score=3 haemorrhagic stroke (15.5% vs 
22.5%, OR=1.9, 95%CI=1.4-2.6). Overall, those with a mRS=2 had LOS on HASUs 
extended by 9.7 days (95%CI=6.8-12.5), mRS=3 by 8.4 days (95%CI=5.2-11.6), and 
mRS=4 or 5 by 5.2 days (95%CI=1.1-9.3). 
Conclusions: Individuals with evidence of pre-stroke disability, assessed by mRS, 





• Post-stroke disability, assessed by the modified Rankin Scale (mRS), is 
commonly used to assess stroke outcomes. 
• There is a paucity of information on pre-stroke disability on stroke outcomes. 
• More severe pre-stroke disability, assessed by mRS, was related to greater risk 
of severe stroke at admission, urinary tract infection and pneumonia within seven 
days of admission, and in-patient mortality by 3.5 to 5-fold, independent of age, 
sex and co-morbidities. 
• Increasing severity of pre-stroke disability also increased the likelihood of 
prolonged length of stay in hyperacute units, extending by 9.7 days for those with 






In line with an increasingly ageing population in industrialised nations over the past 
century [1, 2], the number of adults living with age-related conditions, such as stroke, 
has risen dramatically [3] which result in long-term poor health and disability [4]. 
Information on the severity of post-stroke disability allows healthcare teams to arrange 
appropriate levels of care for patients upon discharge to the community [5], and also 
provides prognosis on stroke outcomes [6] and recovery [7-10]. The ability to predict 
post-stroke complications on admission provides important data that can be used to 
formulate clinical plans for the patient earlier in the care pathway, and allows hospital 
to strategically organise their day-to-day operational matters with more certainty. 
 
The modified Rankin Scale (mRS) is a widely accepted instrument used to assess 
disability after stroke as well as endpoints for research trials [11]. There is now 
increasing interest in the use of pre-stroke disability, assessed by mRS, as a 
prognostic tool for stroke outcomes [12]. However, there is a paucity of published data 
on pre-stroke mRS in relation to post-stroke adverse outcomes in hospital. In the 
present study, we assessed the relationship between pre-stroke disability assessed 
by mRS and a number of post-stroke outcomes during hospitalisation including: 
severity of stroke, haemorrhagic stroke, nosocomial infections, length-of-stay in 
hyperacute stroke units (HASUs) and in-patient mortality. 
 
METHODS 
Study design, participants and setting 
We performed analysis of prospectively collected data from the national register of 
stroke care (Sentinel Stroke National Audit Programme (SSNAP)). The data comprise 
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clinical characteristics and care quality of patients admitted to acute care hospitals in 
England and Wales [13]. Data from the present study were gathered from the time of 
admission up to six months after stroke in patients admitted to four major UK 
hyperacute stroke centres in South East England between January 2014 and February 
2016 [14,15]. 
 
SSNAP has approval from the Confidentiality Advisory Group of the Health Research 
Authority to collect patient data under section 251 of the National Health Service Act 
2006, so that no additional ethical approval was required [9]. 
 
Socio-demographic factors and medical history 
Demographic data were collected and documented by stroke consultants and nurse 
specialists; including age at arrival, gender and coexisting morbidities (atrial fibrillation, 
hypertension, congestive heart failure, diabetes mellitus and previous stroke) [13-15]. 
 
Pre-stroke disability  
The degree of pre-stroke disability or dependence with daily activities was assessed 
by mRS, ranging from no symptoms to severe symptoms: 0 = no symptoms at all, 1 = 
no significant disability despite symptoms; able to carry out all usual duties and 
activities, 2 = slight disability; unable to carry out all previous activities, but able to look 
after their own affairs without assistance; 3 = moderate disability; requiring some help, 
but able to walk without assistance; 4 = moderately severe disability; unable to walk 
without assistance and unable to attend to own bodily needs without assistance; 5 = 





Stroke diagnosis and severity 
Stroke was diagnosed based on clinical presentation and brain imaging [14,15]. The 
severity of stroke symptoms at arrival was assessed by the National Institutes of 
Health for Stroke Scale (NIHSS) with a score range from no symptoms to severe 
stroke symptoms (NIHSS score=0 to 42). 
 
In-patient infections, length of stay and mortality 
Details of new cases of urinary tract infection (UTI) and pneumonia acquired in hospital 
within seven days of admission, length of stay on HASUs and in-patient mortality were 
documented.  
 
Categorisation of variables 
Dichotomisation was applied for atrial fibrillation, congestive heart failure, 
hypertension and diabetes, type of stroke, and in-patient infections and mortality 
according to the presence or absence of history of the condition. Prolonged length of 
stay (LOS) on HASUs was defined as those who stayed longer than three weeks (4th 
quartile) [14,15]. Pre-stroke mRS was categorised into five groups: group 1, mRS 
score = 0; group 2, mRS score = 1; group 3, mRS score = 2; group 4, mRS = 3; and 
group 5, mRS score = 4 or 5 (these last two mRS categories were grouped together 
due to small numbers). Moderately-severe to severe stroke on arrival was defined as 





Multivariable logistic regression analysis was carried out to estimate the risk of severe 
stroke at admission, haemorrhagic stroke, in-patient mortality, urinary and pneumonia 
infections within seven days of admission and LOS on HASUs (dependent variables) 
from pre-stroke disability using patients with mRS score = 0 as the reference group 
(independent variable). The results are presented as two models: model 1, 
unadjusted; model 2, adjusted for age, sex and co-morbidities (atrial fibrillation, 
hypertension, congestive heart failure, diabetes and previous stroke). Results are 
expressed as odds ratios (OR) and 95% confidence intervals (CI). Analyses were 
performed using SPSS V.23.0 (SPSS Inc, Chicago, Illinois, USA). The null hypothesis 
was rejected when p <0.05. 
 
RESULTS 
A total of 3309 patients were admitted with an acute stroke, 1656 men (mean age ±SD 
= 73.1 yr ±13.2) and 1653 women (79.3 yr ±13.0). From these 2758 (83.3%) patients 
presented with ischaemic stroke; of the remainder 518 (15.7%) patients had a 
haemorrhagic stroke and 33 (1.0%) were unspecified. The mean LOS on HASU was 
16.1 days (±21.2). There were 480 (14.5%) patients who died during admission. The 
prevalence of co-existing morbidities including atrial fibrillation and congestive heart 
failure and previous stroke (except a smaller proportion in the mRS = 5 group) rose 
progressively with increasing severity of pre-stroke mRS scores: there was no such 
relationship for diabetes or hypertension. The proportions of individuals with adverse 
post-stroke outcomes also increased progressively with increasing severity of pre-
stroke disability: these included moderately-severe to severe stroke (NIHSS score 
≥16) on admission, UTI and pneumonia within seven days of admission and mortality.  
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However, the rates of prolonged LOS on HASU were greatest in those with mRS 
scores between 2 and 4 (Table 1). 
 
There were significant increases in LOS on HASUs for patients with higher pre-stroke 
mRS scores (p<0.001) (Figure 1). ANOVA showed that compared with patients with 
a pre-stroke mRS score = 0 (reference group), LOS on HASUs was longer for those 
with a pre-stroke mRS score = 1 by 2.6 days (95% CI: 0.3-4.9 days, p = 0.027), pre-
stroke mRS score = 2 by 9.7 days (95% CI: 6.8-12.5 days, p <0.001), pre-stroke mRS 
score = 3 by 8.4 days (95% CI: 5.2-11.6 days, p <0.001), and pre-stroke mRS score 
= 4 and 5 by 5.2 days (95% CI: 1.1-9.3 days, p = 0.013). 
 
Logistic regression showed progressive increase in the risk of having adverse 
outcomes with increasing pre-stroke mRS (Table 2). Compared with patients with 
mRS scores = 0 (reference group), individuals with mRS scores = 4 and 5 had greater 
adjusted risks of: moderately-severe or severe stroke on arrival (4.4% vs 22.1%, OR 
= 4.5, 95%CI = 2.9-7.1); UTI (4.6% vs 23.2%, OR = 4.2, 95%CI = 2.7-6.5), pneumonia 
within seven days of admission (6.7% vs 26.7%, OR = 3.7, 95%CI = 2.5-5.8), UTI 
and/or pneumonia within seven days of admission (9.6% vs 34.7%, OR = 3.4, 95%CI 
= 2.4-5.0); prolonged LOS on HASUs  (20.3% vs 34.6%, OR = 1.6 (1.1-2. 5) and 
mortality (7.2% vs 38.1%, OR = 5.0, 95%CI = 3.5-7.3). Patients in with mRS scores of 
between 2 and 3 had intermediate risk of severe stroke at admission, nosocomial 
infections and mortality. However,  for those with mRS score = 2 there was the highest 
risk of prolonged LOS on HASU (20.3% vs 41.8%, OR = 2.4, 95% CI=1.8-3.2) and for 
those with mRS score =3 the greatest risk of haemorrhagic stroke (15.5% vs 22.5%, 





The majority of studies concerned with the management of stroke patients focus on 
post-stroke disabilities, assessed by mRS.  By contrast, there are few data on the use 
of a pre-stroke mRS score as a prognostic indicator of stroke outcomes. For 
individuals with moderately-severe to severe pre-stroke disabilities (mRS score = 4 or 
5) there was a 3- to 4-fold increase in the risk for having severe stroke itself, 
nosocomial infections, in-patient mortality and a 2-fold increase for prolonged stay on 
HASU; all these outcomes were independent of age, sex and a range of major co-
existing morbidities. 
 
We found the severity of pre-stroke disability related continuously with some post-
stroke outcomes including: the severity of stroke at admission; nosocomial infections; 
and in-patient mortality. However, the risk of prolonged LOS in HASU and 
haemorrhagic stroke was highest among those with intermediate pre-stroke mRS 
scores (2 or 3). It is possible that the higher in-patient mortality of those patients with 
greater severe pre-stroke disability (mRS score 4 or 5) may contribute to the shorter 
LOS among these patients and that those with haemorrhagic stroke are at greater risk 
of death. 
 
Although effort was made to adjust for major co-existing morbidities in our analysis, 
the risk of pre-stroke mRS with post-stroke adverse outcomes suggests that patients 
with pre-existing disabilities are more likely to be more frail and susceptible to common 
infections with diminished ability to recover from an illness [19,20], leading to 
increased risk of prolonged LOS on HASUs and mortality. Our observations are 
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consistent with a previous study on the associations between pre-stroke mRS scores 
and adverse outcomes [12]. 
 
Acute stroke usually evolves into a chronic condition. The majority of individuals with 
a stroke require after-care including rehabilitation and frequent hospital admissions or 
clinic visits, as well as more different medications [17,18]. Disability [21], frailty [22], 
impaired quality of life [23] and cognitive impairment [4], that arising from stroke, 
impose enormous personal costs and burdens on healthcare systems [24]. Given the 
increasing life expectancy of the population in the UK and other industrialised nations 
[1, 2], more people are living with stroke than ever.  This means the adverse health 
outcomes from stroke will continue to increase these personal  and healthcare costs. 
Therefore it is necessary to recognise earlier those patients with pre-stroke disability, 
indicated by high mRS scores, to reduce the risk of adverse complications from stroke, 
including nosocomial infections, as well as increased in-patient LOS and mortality. 
 
Strengths and limitations 
The strengths of the present study lie in its large cohort of patients derived from one 
of the largest NHS regions in the UK and who have similar characteristics to the rest 
of the UK [18, 19, 22]. The data were collected in accordance with the national SSNAP 
protocol and analysis took a range of confounding factors known to associate with 
stroke outcomes into account. We chose a cut-off point for NIHSS scores of ≥16 
(moderately-severe to severe stroke) based on previous studies that demonstrated a 
strong prediction of mortality or severe disability [25], while cut-off intervals for mRS 
score at 0-1, 2-3, and 4-5 indicated worsening functional disability due to increasing 
severity of stroke [26]. “Prolonged stay” tends to vary between studies which 
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generates a problem that the longer is this time, the greater is the severity of conditions 
that cause a prolonged stay. In this study, we specifically defined it as for patients who 
stayed on HASUs for more than three weeks, which represents the upper quartile of 
LOS on HASUs. 
 
In conclusion, individuals with increasing pre-stroke disability, assessed by mRS, were 
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Figure 1. Plot showing mean LOS on HASUs in relation to different level of pre-stroke 
disability assessed by mRS scores. *Significances from pre-stroke mRS score = 0 
(reference group).  
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Table 1. Proportions of patients (1288 men and 1255 women) admitted with first stroke with co-existing morbidities and adverse 
outcomes. 
 mRS = 0  
(n = 2003) 
mRS = 1 
(n = 476) 
mRS = 2 
(n = 340) 
mRS = 3 
(n = 309) 
mRS = 4 
(n = 143) 
mRS = 5 
(n=38) 
Group differences 
Co-existing morbidities % %  %  % χ2 p 
Atrial fibrillation 15.6 24.2 25.6 30.1 36.4 18.4 79.5 <0.001 
Congestive heart failure 3.6 8.6 9.1 9.4 11.9 10.5 49.6 <0.001 
Hypertension 50.4 60.3 53.2 53.1 51.0 39.5 18.0 0.003 
Diabetes mellitus 15.0 19.1 14.4 17.2 21.0 21.1 9.3 0.099 
Previous stroke 16.4 30.7 31.8 36.6 39.9 34.2 136.6 <0.001 
Post-stroke adverse outcomes         
Haemorrhagic stroke 15.0 13.7 17.9 22.5 13.5 19.4 14,7 0.012 
NIHSS ≥16 on arrival 4.4 6.5 7.6 13.6 22.4 21.1 107.3 <0.001 
UTI within 7 days of admission 4.6 6.5 9.2 17.7 24.5 18.4 131.2 <0.001 
Pneumonia within 7 days of admission 6.7 10.7 13.5 29.7 25.4 31.6 186.2 <0.001 
UTI and/or pneumonia within 7 days of 
admission 
9.6 13.0 19.3 36.7 34.1 36.8 213.8 <0.001 
Prolonged LOS on HASUs 20.3 26.9 41.8 38.4 37.2 23.8 80.8 <0.001 




Table 2. Logistic regression to assess the risk of post-stroke adverse outcomes in older patients with acute stroke. Reference 
group: mRS = 0 (n = 2012). 
 mRS = 1 
(n = 476) 
mRS = 2 
(n = 340) 
mRS = 3 
(n = 309) 
mRS = 4 and 5 
(n = 181) 
Unadjusted OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
Intracranial haemorrhagic stroke 0.90 0.68-1.20 0.482 1.23 0.91-1.68 0.176 1.64 1.22-2.20 0.001 0.97 0.63-1.50 0.906 
NIHSS ≥16 on arrival 1.52 0.99-2.31 0.053 1.80 1.15-2.84 0.011 3.42 2.32-5.05 <0.001 6.17 4.09-9.31 <0.001 
UTI within 7 days of admission 1.43 0.94-2.18 0.098 2.08 1.35-3.21 0.001 4.41 3.96-6.35 <0.001 6.20 4.12-9.33 <0.001 
Pneumonia within 7days of admission 1.65 1.17-2.34 0.004 2.16 1.50-3.12 <0.001 5.85 4.31-7.94 <0.001 5.05 3.46-7.38 <0.001 
UTI and/or pneumonia within 7days of 
admission 
1.41 1.04-1.93 0.029 2.26 1.65-3.09 <0.001 5.46 4.13-7.22 <0.001 5.00 3.54-7.06 <0.001 
Prolonged LOS on HASUs 1.44 1.11-1.85 0.005 2.82 2.12-3.75 <0.001 2.50 1.83-3.43 <0.001 2.08 1.38-3.16 0.001 
Mortality 2.12 1.56-2.88 <0.001 4.31 3.20-5.80 <0.001 7.34 5.52-9.74 <0.001 7.98 5.66-11.24 <0.001 
Adjusted             
Intracranial haemorrhagic stroke 0.98 0.73-1.32 0.910 1.37 1.00-1.88 0.051 1.89 1.38-2.59 <0.001 1.15 0.73-1.82 0.534 
NIHSS ≥16 on arrival 1.29 0.84-1.99 0.246 1.45 0.91-2.32 0.122 2.56 1.68-3.89 <0.001 4.53 2.90-7.07 <0.001 
UTI within 7 days of admission 1.13 0.73-1.76 0.580 1.58 1.01-2.48 0.045 3.08 2.07-4.57 <0.001 4.16 2.66-6.51 <0.001 
Pneumonia within 7days of admission 1.33 0.93-1.90 0.120 1.70 1.16-2.48 0.006 4.34 3.11-6.06 <0.001 3.72 2.47-5.81 <0.001 
UTI and/or pneumonia within 7days of 
admission 
1.10 0.80-1.52 0.557 1.71 1.23-2.38 0.001 3.86 2.85-5.23 <0.001 3.44 2.37-5.00 <0.001 
Prolonged LOS on HASUs 1.25 0.96-1.63 0.093 2.38 1.77-3.20 <0.001 1.92 1.38-2.68 <0.001 1.63 1.06-2.51 0.027 
Mortality 1.66 1.20-2.28 0.002 3.21 2.35-4.37 <0.001 4.92 3.61-6.69 <0.001 5.03 3.48-7.28 <0.001 




Figure 1. Plot showing mean LOS on HASUs in relation to different level of pre-stroke 
disability assessed by mRS scores. *Significances from pre-stroke mRS score = 0 
(reference group). 
 
